Print this page

Fresenius Kabi Neonatal Parenteral Nutrition (PN) Study Day 2016

Learning from the forefront of practice…

On the 4th October, Fresenius Kabi held a study day ‘Clinical and practical factors shaping the future of neonatal parenteral nutrition’ in central London. During the meeting, attendees were treated to a series of ‘hot-topic’ presentations delivered by some of the most knowledgeable and experienced healthcare professionals involved in neonatal PN in the UK.

 
Dr Colin Morgan (Consultant Neonatologist, Liverpool Women’s Hospital and lead investigator of the SCAMP study) gave the first two highly engaging presentations which discussed strategies for optimising parenteral nutrient intake, and the interpretation of preterm PN studies. These were followed by the latest practice framework for neonatal PN of the British Association of Perinatal Medicine (BAPM) presented by Steve Tomlin, Consultant Pharmacist at the Evelina London Children’s hospital. Tony Murphy (Pharmacy Production Manager University College London Hospitals and meeting chair), then shared with the audience the deliberations and output of the most recent (April 2016) neonatal advisory board held by Fresenius Kabi. This meeting had been set up to bring a group of key specialists together to discuss approaches and recommend a fitting range of standardised neonatal PN formulations in light of the current body of evidence and contemporary practice.

 
Following the presentations, the attendees were given the opportunity to provide some insight into their current neonatal PN practice and feedback on the proposals of the advisory board via an interactive voting session. 76% of the voters indicated they currently use some standardised neonatal PN formulations with over 50% using standardised formulations for both short- and long-term use. Remarkably, despite some differences in opinion regarding the finer detail of the formulations suggested by the advisory board, a staggering 97% of the voters indicated they believe the formulation content of standardised neonatal PN formulations should be determined at national level.

 
We would like to say a big thank you to the wonderful speakers and to everyone who attended the meeting – we hope you found the day enjoyable.

 
A copy of the presentations and the summary report of the advisory board meeting is available from PN.studyday2016@fresenius-kabi.com

 
If you would like to get involved with any initiatives in neonatal PN that Fresenius Kabi may run in the future then please email PN.studyday2016@fresenius-kabi.com with a brief explanation of your experience and interest in this area.